Investor relations

Presentations

Shareholders

Shareholder Information


Lytix Biopharma is a private clinical stage company. In addition to equity financing the company has qualified to substantial funding from public grants. Following successful Phase II results, Lytix Biopharma will seek partnerships with industry majors for late stage development and commercialisation. IPO / stock exchange listing is under consideration.